Agilent Technologies, Inc. (NYSE:A) Shares Purchased by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 48.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 443 shares of the medical research company’s stock after purchasing an additional 145 shares during the period. TD Waterhouse Canada Inc.’s holdings in Agilent Technologies were worth $60,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CKW Financial Group increased its position in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after acquiring an additional 100 shares during the period. Global X Japan Co. Ltd. boosted its stake in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 116 shares in the last quarter. Redwood Park Advisors LLC acquired a new position in Agilent Technologies in the fourth quarter valued at $27,000. Lee Danner & Bass Inc. acquired a new position in Agilent Technologies in the fourth quarter valued at $29,000. Finally, Hanson & Doremus Investment Management boosted its stake in Agilent Technologies by 66.5% in the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 105 shares in the last quarter.

Insider Activity

In other news, Director Daniel K. Podolsky sold 1,819 shares of the company’s stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares in the company, valued at approximately $4,161,931.02. This represents a 4.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the transaction, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Stock Down 0.7 %

Agilent Technologies stock opened at $106.31 on Monday. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $155.35. The stock has a market cap of $30.31 billion, a price-to-earnings ratio of 24.44, a PEG ratio of 3.00 and a beta of 1.19. The company’s 50-day moving average price is $116.40 and its two-hundred day moving average price is $130.92. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, analysts expect that Agilent Technologies, Inc. will post 5.54 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were given a dividend of $0.248 per share. The ex-dividend date was Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.93%. Agilent Technologies’s payout ratio is presently 22.76%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on A shares. Barclays decreased their target price on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a research note on Thursday, April 10th. TD Cowen lifted their price target on shares of Agilent Technologies to $135.00 and gave the company a “buy” rating in a research report on Thursday, April 10th. Robert W. Baird lowered their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday, February 27th. Wells Fargo & Company lowered their target price on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a report on Thursday, April 17th. Finally, Jefferies Financial Group lowered their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a “hold” rating for the company in a report on Monday, April 21st. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $143.00.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.